Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Clinical Nuclear Medicine|April 26, 2020
Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the EsophagusRomain-David Seban, Laurence Bozec, Laurence ChampionClinical Nuclear Medicine|November 12, 2020
Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted TherapiesRomain-David Seban, Laurence Bozec, Camila Nascimento-Leite, et al.Diagnostics (Basel, Switzerland)|April 30, 2021
Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 VaccineRomain-David Seban, Laurence Champion, Nicolas Deleval, et al.Clinical Nuclear Medicine|May 9, 2017
The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated FusariosisRomain-David Seban, Gérald Bonardel, Mohamed Guernou, et al.Clinical Nuclear Medicine|February 28, 2023
68 Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous TumorCapucine Richard, Jérôme Cros, Romain-David Seban, et al.Diagnostics (Basel, Switzerland)|April 30, 2021
Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CTRomain-David Seban, Camille Vermersch, Laurence Champion, et al.Journal of Clinical Medicine|January 21, 2023
Advances in PET/CT Imaging for Breast Cancer Patients and BeyondDavid Khalil, Andrew Lotfalla, Antoine Girard, et al.Seminars in Cancer Biology|April 30, 2022
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imagingAgathe Peltier, Romain-David Seban, Irène Buvat, et al.Current Cancer Drug Targets|July 21, 2021
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be OverlookedRomain-David Seban, Shwe Synn, Izza Muneer, et al.Diagnostics (Basel, Switzerland)|August 27, 2021
18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor DostarlimabRomain-David Seban, Anne Donnadieu, Gabrielle Journo, et al.Pageof 5